Merck Millipore , Ltd. · Class II · Cleared Mar 27, 2014
| K-number | K133004 |
| Device name | VENTED MILLEX -GV, CATHIVEX -GV |
| Applicant | Merck Millipore , Ltd. |
| Product code | BSN |
| Device class | Class II |
| Decision date | Mar 27, 2014 |
| Decision | Substantially Equivalent |
| Regulation | 868.5130 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov